Vita Life Sciences Limited

ASX:VLS Voorraadrapport

Marktkapitalisatie: AU$118.4m

Vita Life Sciences Inkomsten in het verleden

Verleden criteriumcontroles 4/6

Vita Life Sciences is de winst gegroeid met een gemiddeld jaarlijks percentage van 19.8%, terwijl de Pharmaceuticals industrie de winst jaarlijks groeide met 35.4%. De inkomsten zijn gegroeid met een gemiddelde snelheid van 14.1% per jaar. Het rendement op eigen vermogen van Vita Life Sciences is 19.3%, en het heeft een nettomarge van 11.9%.

Belangrijke informatie

19.8%

Groei van de winst

19.7%

Groei van de winst per aandeel

Pharmaceuticals Groei van de industrie31.2%
Inkomstengroei14.1%
Rendement op eigen vermogen19.3%
Nettomarge11.9%
Laatste winstupdate30 Jun 2024

Recente prestatie-updates uit het verleden

Recent updates

Vita Life Sciences Limited (ASX:VLS) Looks Inexpensive But Perhaps Not Attractive Enough

Sep 23
Vita Life Sciences Limited (ASX:VLS) Looks Inexpensive But Perhaps Not Attractive Enough

Vita Life Sciences (ASX:VLS) Has Announced A Dividend Of A$0.035

Aug 28
Vita Life Sciences (ASX:VLS) Has Announced A Dividend Of A$0.035

Vita Life Sciences Limited (ASX:VLS) Stock Catapults 26% Though Its Price And Business Still Lag The Market

Mar 22
Vita Life Sciences Limited (ASX:VLS) Stock Catapults 26% Though Its Price And Business Still Lag The Market

Vita Life Sciences (ASX:VLS) Has Announced That It Will Be Increasing Its Dividend To A$0.06

Mar 14
Vita Life Sciences (ASX:VLS) Has Announced That It Will Be Increasing Its Dividend To A$0.06

Vita Life Sciences' (ASX:VLS) Shareholders Will Receive A Bigger Dividend Than Last Year

Feb 28
Vita Life Sciences' (ASX:VLS) Shareholders Will Receive A Bigger Dividend Than Last Year

A Look At The Fair Value Of Vita Life Sciences Limited (ASX:VLS)

Dec 20
A Look At The Fair Value Of Vita Life Sciences Limited (ASX:VLS)

Should You Be Adding Vita Life Sciences (ASX:VLS) To Your Watchlist Today?

Aug 24
Should You Be Adding Vita Life Sciences (ASX:VLS) To Your Watchlist Today?

If You Like EPS Growth Then Check Out Vita Life Sciences (ASX:VLS) Before It's Too Late

May 14
If You Like EPS Growth Then Check Out Vita Life Sciences (ASX:VLS) Before It's Too Late

Did Vita Life Sciences' (ASX:VLS) Share Price Deserve to Gain 83%?

Mar 18
Did Vita Life Sciences' (ASX:VLS) Share Price Deserve to Gain 83%?

Vita Life Sciences Limited (ASX:VLS) On An Uptrend: Could Fundamentals Be Driving The Stock?

Feb 17
Vita Life Sciences Limited (ASX:VLS) On An Uptrend: Could Fundamentals Be Driving The Stock?

Vita Life Sciences (ASX:VLS) Is Growing Earnings But Are They A Good Guide?

Jan 20
Vita Life Sciences (ASX:VLS) Is Growing Earnings But Are They A Good Guide?

Here's Why We Think Vita Life Sciences (ASX:VLS) Is Well Worth Watching

Dec 22
Here's Why We Think Vita Life Sciences (ASX:VLS) Is Well Worth Watching

Vita Life Sciences Limited's (ASX:VLS) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?

Nov 19
Vita Life Sciences Limited's (ASX:VLS) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?

Vita Life Sciences Limited's (ASX:VLS) Prospects Need A Boost To Lift Shares

Jul 14
Vita Life Sciences Limited's (ASX:VLS) Prospects Need A Boost To Lift Shares

Opbrengsten en kosten

Hoe Vita Life Sciences geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.


Inkomsten en omzetgeschiedenis

ASX:VLS Opbrengsten, kosten en inkomsten (AUD Millions )
DatumInkomstenInkomstenG+A UitgavenR&D-uitgaven
30 Jun 24799340
31 Mar 24779320
31 Dec 23749310
30 Sep 23718300
30 Jun 23697290
31 Mar 23687290
31 Dec 22677290
30 Sep 22658270
30 Jun 22648260
31 Mar 22618250
31 Dec 21578240
30 Sep 21548230
30 Jun 21507220
31 Mar 21486220
31 Dec 20466210
30 Sep 20466220
30 Jun 20455220
31 Mar 20444230
31 Dec 19423230
30 Sep 19422230
30 Jun 19412230
31 Mar 19412220
31 Dec 18412210
30 Sep 18403210
30 Jun 18404210
31 Mar 18383200
31 Dec 17373200
30 Sep 17373200
30 Jun 17373200
31 Mar 17383200
31 Dec 16383200
30 Sep 16384200
30 Jun 16385200
31 Mar 16395210
31 Dec 15394210
30 Sep 15384200
30 Jun 15374200
31 Mar 15376200
31 Dec 14377190
30 Sep 14367190
30 Jun 14367190
31 Mar 14366190
31 Dec 13355180

Kwaliteitswinsten: VLS heeft hoge kwaliteitsinkomsten.

Groeiende winstmarge: De huidige netto winstmarges (11.9%) VLS } zijn hoger dan vorig jaar (10.8%).


Analyse vrije kasstroom versus winst


Analyse van de winstgroei in het verleden

Winsttrend: De winst van VLS is de afgelopen 5 jaar met 19.8% per jaar gegroeid.

Versnelling van de groei: De winstgroei van VLS over het afgelopen jaar ( 26.6% ) overtreft het 5-jarig gemiddelde ( 19.8% per jaar).

Winst versus industrie: De winstgroei VLS over het afgelopen jaar ( 26.6% ) overtrof de Pharmaceuticals -sector 46.5%.


Rendement op eigen vermogen

Hoge ROE: Het Rendement op eigen vermogen ( 19.3% ) van VLS wordt als laag beschouwd.


Rendement op activa


Rendement op geïnvesteerd vermogen


Ontdek sterk presterende bedrijven uit het verleden